Premium
Biotransformation of epomediol. I—isolation and identification of main metabolites in the rat
Author(s) -
Ventura Paolo,
Selva Antonio
Publication year - 1982
Publication title -
biomedical mass spectrometry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 121
eISSN - 1096-9888
pISSN - 0306-042X
DOI - 10.1002/bms.1200090105
Subject(s) - isolation (microbiology) , biotransformation , identification (biology) , computational biology , chemistry , biology , microbiology and biotechnology , biochemistry , botany , enzyme
The identification of biotransformation products of the new choleretic drug epomediol in rat has been performed by means of mass spectral, proton magnetic resonance and infrared techniques. The drug was administered perorally or intravenously; urine, bile and faeces were collected and the metabolites isolated. In urine, three metabolites were found in addition to the unchanged drug, namely: 1,3,3‐trimethyl‐2‐oxabicyclo[2.2.2]octan‐6‐hydroxy‐7‐one, 1,3‐dimethyl‐2‐oxabicyclo[2.2.2]octan‐6,7‐hydroxy‐10‐methanol and 1,3,3‐trimethyl‐2‐oxabicyclo[2.2.2.]octan‐6‐β‐glucuronide‐7‐ol. In bile only the glucuronide and the unchanged drug were found. Analogously, in faeces the glucuronide and the drug were also identified, but only in trace amounts. This fact may suggest the presence of an enterohepatic circulation of the drug.